CharlesHenryNashIIIMD

Clinical Trials

• Lung-MAP: Palbociclib as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Jun 01Vassiliki Papadimitrakopoulou
• Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer Start of enrollment: 2013 Apr 01Pillai, P.,Berenberg, J.L.,Wade, J.L.,Miller, K.D.,Dakhil, S.R.,Chintapalli, N.,Aylesworth, C.A.,Flaherty, L.E.,Friedberg, J.E.,Marchello, B.T.,Chay, C.H.,Watanaboonyakhet, P.,Scott, M.T.,Nimeh, N.F.,Zehn...
• S0820, Adenoma and Second Primary Prevention Trial Start of enrollment: 2013 Mar 01Tolentino, A.R.,Neugut, A.I.,Johal, A.S.,Karnad, A.B.,Muskovitz, A.A.,Pippas, A.W.,McIntyre, A.P.,Gregory, A.K.,Advani, A.S.,Jaslowski, A.J.,Baron, A.D.,Vemula, A.Y.,Marchello, B.T.,Barai, B.H.,Minniti, C...
• S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Start of enrollment: 2013 Mar 01Allen, A.,Alva, A.S.,Leaf, A.N.,Pippas, A.W.,Maini, A.,Baron, A.D.,Craft, B.S.,Kasimis, B.S.,Gartrell, B.A.,Marchello, B.T.,Cutler, B.J.,Friday, B.E.,Freter, C.E.,Paller, C.J.,Nash, C.H.,Chen, C.(.,Chay, ...
• PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score Start of enrollment: 2012 May 01Dooley, W.C.,Whitworth, P.W.,Oldham, D.S.,Riseberg, D.A.,Soliman, H.,Berkowitz, M.J.,Favis, G.,Srinivasiah, J.,Mroz, C.T.,Gunn, S.,Gorbaty, M.,Tsai, M.,Komenaka, I.K.,Durkin, W.J.,Shah, S.N.,Barginear, M....
• A Randomized Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain and Stiffness In Women With Early Stage Breast Cancer, Phase III Start of enrollment: 2012 Feb 01Atkins, J.N.,Baker, L.H.,Bearden, J.D.,Beck, J.T.,Beeker, T.A.,Boone, R.,Carolla, R.L.,Chew, H.K.,Clarkson, J.E.,Cutler, B.J.,D'Abreo, N.,Dakhil, S.R.,Fehrenbacher, L.,Feusner, J.H.,Gaur, R.,Giguere, J.K....
• Prospective Neo-adjuvant REGISTRY Trial Linking MammaPrint, Subtyping and Treatment Response: Neoadjuvant Breast Registry - Symphony Trial (NBRST) (Pronounced "in Breast") Start of enrollment: 2011 Jul 01Clarence Sarkodee Adoo, MD, Dr Finkelstein, MD, Margaret Hadcock, MD, Steven Hagar, MD, Bichlien Nguyen, MD, John Link, MD, Mike Stuntz, MD, Lisa Bailey, MD, Laura Lee, MD, Kristi Bobolis, MD, Robert Baro...
• A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive and Her2-Negative Breast Cancer With Recurrence Score (RS) of 25 or Less Start of enrollment: 2011 Jan 01(Mohamed), T.E.,Abraham, J.,Advani, A.S.,Agarwala, S.S.,Allada, N.,Arce-Salinas, C.H.,Atkins, J.N.,Averbook, B.J.,Aziz, S.,Baez-Diaz, L.,Barhamand, F.B.,Barreau, J.G.,Bearden, J.D.,Beeker, T.A.,Behrens, R...
• A RANDOMIZED PHASE II TRIAL OF WEEKLY NANOPARTICLE ALBUMIN BOUND PACLITAXEL (NAB-PACLITAXEL) (NSC-736631) WITH OR WITHOUT BEVACIZUMAB, EITHER PRECEDED BY OR FOLLOWED BY Q 2 WEEK DOXORUBICIN (A) AND CYCLOPHOSPHAMIDE ©) PLUS PEGFILGRASTIM (PEG-G) AS NEOADJ Start of enrollment: 2010 Apr 01Atkins, J.N.,Beck, J.T.,Beeker, T.A.,Berenberg, J.L.,Carolla, R.L.,Chew, H.K.,Colman, L.K.,Craft, B.S.,Dakhil, S.R.,Feusner, J.H.,Friedberg, J.W.,Gross, H.M.,Harrer, G.W.,Kuebler, J.P.,Lyons, S.E.,Marchel...
• A Prospective Observational Multicenter Cohort Study to Assess the Incidence of Osteonecrosis of the Jaw (ONJ) in Cancer Patients With Bone Metastases Starting Zoledronic Acid Treatment Start of enrollment: 2008 Dec 01(Mohamed), T.E.,Al-Janadi, A.,Arrieta-Rodriguez, O.G.,Atkins, J.N.,Bearden, J.D.,Beck, L.K.,Beeker, T.A.,Behrens, R.J.,Berenberg, J.L.,Bhoopalam, N.,Catchatourian, R.,Chapman, R.A.,Chaudhri, N.A.,Chew, H....
• Phase II Trial of mTOR Inhibitor, Everolimus (RAD001), in Malignant Pleural Mesothelioma (MPM) Start of enrollment: 2008 Dec 01Atkins, J.N.,Cathcart-Rake, W.F.,Dakhil, S.R.,Fisher, R.I.,Gandara, D.R.,Garland, L.,Gross, H.M.,Kuebler, J.P.,Marchello, B.T.,Mathews, M.R.,Nash, C.H.,Ou, S.I.,Rivkin, S.E.,Ruzich, J.C.,Stella, P.J.
• Phase III Prospective Randomized Comparison of Depot Octreotide Plus Interferon Alpha Versus Depot Octreotide Plus Bevacizumab (NSC #704865) in Advanced, Poor Prognosis Carcinoid Patients Start of enrollment: 2007 Dec 01Atkins, J.N.,Averbook, B.J.,Axelrod, R.S.,Beck, J.T.,Beeker, T.A.,Benson, A.B.,Carolla, R.L.,Constantinou, C.L.,Dakhil, S.R.,Dobbs, T.W.,Ellerton, J.A.,Flynn, P.J.,Friedman, E.L.,Giguere, J.K.,Gonzales-Ch...
• A Phase II Trial of the Combination of OSI-774 (ERLOTINIB; NSC-718781) and Bevacizumab (Rhumab VEGF; NSC-704865) in Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features (ADENOBAC) Start of enrollment: 2007 Jul 01Atkins, J.N.,Bearden, J.D.,Blachly, R.J.,Bury, M.J.,Cathcart-Rake, W.F.,Clarkson, J.E.,Dakhil, S.R.,Fehrenbacher, L.,Grimm, R.A.,Harker, W.G.,Harrer, G.W.,Irwin, D.H.,Kuebler, J.P.,Lau, D.H.,Marchello, B....
• http://clinicaltrials.gov/ct2/show/NCT02785952
• http://clinicaltrials.gov/ct2/show/NCT02785913
• Join now to see all